 | | | | Related Healthscout Videos | |
|
MONDAY, April 7 (HealthDay News) -- In the continuing search to uncover the benefits and risks of hormone therapy for women, a new study suggests that the amount of hormone a woman takes may determine whether it helps or harms her.
The study, done with mice, found that lower doses of estrogen were safer, while moderate and high doses increased the risk of kidney and heart problems.
Text Continues Below
And although the findings were in rodents, they may provide a glimmer of insight for humans as well.
"It brings to our attention the fact that HRT [hormone replacement therapy] is not something we totally have to dismiss," said Dr. Suzanne Steinbaum, director of Women and Heart Disease at Lenox Hill Hospital in New York City. "There might be a way to give this more safely to women."
The findings were expected to be presented April 7 at the American Physiological Society annual meeting, part of the Experimental Biology 2008 scientific conference, in San Diego. The study was conducted by researchers at the Hypertension and Vascular Research Division of Henry Ford Hospital in Detroit.
A section of the original Women's Health Initiative (WHI), which was designed to look at health issues in postmenopausal women, was halted in 2002, when U.S. researchers found that hormone therapy led to an increased risk of adverse events that included heart attack, stroke, breast cancer and blood clots. The risk depended on whether the woman was taking estrogen alone or estrogen plus progestin, another female hormone.
At the time the trial started, older women at high risk of cardiovascular disease or who already had a diagnosis were commonly taking hormone therapy to reduce their future risk.
Since the halting of the WHI, however, it has become increasingly clear that hormone therapy has different benefits and risks, depending on several different factors.
Page: 1 | 2 | Next >>
|
.gif)
